ES2087038A1 - Nuevas piperidinas con actividad antagonista del paf. - Google Patents

Nuevas piperidinas con actividad antagonista del paf.

Info

Publication number
ES2087038A1
ES2087038A1 ES09402291A ES9402291A ES2087038A1 ES 2087038 A1 ES2087038 A1 ES 2087038A1 ES 09402291 A ES09402291 A ES 09402291A ES 9402291 A ES9402291 A ES 9402291A ES 2087038 A1 ES2087038 A1 ES 2087038A1
Authority
ES
Spain
Prior art keywords
antagonist activity
piperidine derivatives
paf antagonist
novel piperidine
paf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09402291A
Other languages
English (en)
Other versions
ES2087038B1 (es
Inventor
Elena Carceller
J Perre Jimenez
Nuria Recasens
Jordi Salas
Carmen Almansa
Javier Bartroli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noucor Health SA
Original Assignee
J Uriach y Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES09402291A priority Critical patent/ES2087038B1/es
Application filed by J Uriach y Cia SA filed Critical J Uriach y Cia SA
Priority to EP95932668A priority patent/EP0738269B1/en
Priority to DE69516503T priority patent/DE69516503T2/de
Priority to MXPA/A/1996/002559A priority patent/MXPA96002559A/es
Priority to DK95932668T priority patent/DK0738269T5/da
Priority to KR1019960703655A priority patent/KR100514201B1/ko
Priority to AU35636/95A priority patent/AU3563695A/en
Priority to PCT/EP1995/003487 priority patent/WO1996014317A1/en
Priority to JP51497296A priority patent/JP4018137B2/ja
Priority to AT95932668T priority patent/ATE192152T1/de
Priority to ES95932668T priority patent/ES2147616T3/es
Priority to PT95932668T priority patent/PT738269E/pt
Priority to US08/669,440 priority patent/US5705504A/en
Priority to CA002180660A priority patent/CA2180660C/en
Publication of ES2087038A1 publication Critical patent/ES2087038A1/es
Priority to NO962855A priority patent/NO306345B1/no
Application granted granted Critical
Publication of ES2087038B1 publication Critical patent/ES2087038B1/es
Priority to GR20000401219T priority patent/GR3033528T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

COMPUESTOS DE FORMULA I, DONDE M REPRESENTA 0,1 O 2; R1 REPRESENTA C1-4 ALQUILO; B REPRESENTA ZCR2R3-X-(CH2)N), CR2R3=CH- O R7N(Y)-CH2-; N REPRESENTA 0 O 1; X REPRESENTA NH O UN ENLACE SENCILLO; UNO DE R2 O R3 REPRESENTA C1-4 ALQUILO, C3-6 CICLOALQUILO O ARILO, Y EL OTRO REPRESENTA HIDROGENO, C1-4 ALQUILO, C1-4 HALOALQUILO, C3-6 CICLOALQUILO O ARILO; Z REPRESENTA HIDROGENO, C1-4 ALQUILO, (CH2-OR4, -COOR4 O -CONR4R5, Y CUANDO X REPRESENTA ENLACE SENCILLO, Z PUEDE SER TAMBIEN HIDROXI, (NR4R5, (NR6C(=O)OR4, -NR6C(=O)R4, -NR6C(=O)NR4R5, -N(OH)C(=O)NR4R5 O -NR6SO2R4; R4 REPRESENTA HIDROGENO, C1-4 ALQUILO, ARILO O ARIL-C1-4 ALQUILO; R5 Y R6 REPRESENTAN HIDROGENO O C1-4 ALQUILO; R7 REPRESENTA C1-4 ALQUILO, C3-6 CICIOALQUILO O ARILO; E Y REPRESENTA HIDROGENO, C1-4 ALQUILO, ARILO, ARIL-C1-4 ALQUILO, -C(=O)OR4, -C(=O)R4, -C(=O)NR4R5, O -SO2R4. ESTOS COMPUESTOS SON ANTAGONISTAS DEL PAF.
ES09402291A 1994-11-07 1994-11-07 Nuevas piperidinas con actividad antagonista del paf. Expired - Fee Related ES2087038B1 (es)

Priority Applications (16)

Application Number Priority Date Filing Date Title
ES09402291A ES2087038B1 (es) 1994-11-07 1994-11-07 Nuevas piperidinas con actividad antagonista del paf.
ES95932668T ES2147616T3 (es) 1994-11-07 1995-09-05 Derivados de piperidina con actividad antagonista del paf.
MXPA/A/1996/002559A MXPA96002559A (es) 1994-11-07 1995-09-05 Nuevos derivados de piperidina con actividadantagonista del paf
DK95932668T DK0738269T5 (da) 1994-11-07 1995-09-05 Piperidinderivater med PAF-antagonistaktivitet
KR1019960703655A KR100514201B1 (ko) 1994-11-07 1995-09-05 피에이에프길항활성을갖는피페리딘유도체
AU35636/95A AU3563695A (en) 1994-11-07 1995-09-05 Novel piperidine derivatives with paf antagonist activity
PCT/EP1995/003487 WO1996014317A1 (en) 1994-11-07 1995-09-05 Novel piperidine derivatives with paf antagonist activity
JP51497296A JP4018137B2 (ja) 1994-11-07 1995-09-05 Ｐａｆアンタゴニスト活性を有する新規ピぺリジン誘導体
EP95932668A EP0738269B1 (en) 1994-11-07 1995-09-05 Piperidine derivatives with paf antagonist activity
DE69516503T DE69516503T2 (de) 1994-11-07 1995-09-05 Piperidinderivate mit paf antagonistischer wirkung
PT95932668T PT738269E (pt) 1994-11-07 1995-09-05 Derivados de piperidina com actividade antagonista de paf
US08/669,440 US5705504A (en) 1994-11-07 1995-09-05 Piperidine derivatives with PAF antagonist activity
CA002180660A CA2180660C (en) 1994-11-07 1995-09-05 Novel piperidine derivatives with paf antagonist activity
AT95932668T ATE192152T1 (de) 1994-11-07 1995-09-05 Piperidinderivate mit paf antagonistischer wirkung
NO962855A NO306345B1 (no) 1994-11-07 1996-07-05 Piperidin-derivater med PAF antagonist-aktivitet, anvendelse derav og farmasöytisk blanding
GR20000401219T GR3033528T3 (en) 1994-11-07 2000-05-29 Novel piperidine derivatives with paf antagonist activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09402291A ES2087038B1 (es) 1994-11-07 1994-11-07 Nuevas piperidinas con actividad antagonista del paf.

Publications (2)

Publication Number Publication Date
ES2087038A1 true ES2087038A1 (es) 1996-07-01
ES2087038B1 ES2087038B1 (es) 1997-03-16

Family

ID=8287905

Family Applications (2)

Application Number Title Priority Date Filing Date
ES09402291A Expired - Fee Related ES2087038B1 (es) 1994-11-07 1994-11-07 Nuevas piperidinas con actividad antagonista del paf.
ES95932668T Expired - Lifetime ES2147616T3 (es) 1994-11-07 1995-09-05 Derivados de piperidina con actividad antagonista del paf.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES95932668T Expired - Lifetime ES2147616T3 (es) 1994-11-07 1995-09-05 Derivados de piperidina con actividad antagonista del paf.

Country Status (13)

Country Link
US (1) US5705504A (es)
EP (1) EP0738269B1 (es)
JP (1) JP4018137B2 (es)
KR (1) KR100514201B1 (es)
AT (1) ATE192152T1 (es)
AU (1) AU3563695A (es)
DE (1) DE69516503T2 (es)
DK (1) DK0738269T5 (es)
ES (2) ES2087038B1 (es)
GR (1) GR3033528T3 (es)
NO (1) NO306345B1 (es)
PT (1) PT738269E (es)
WO (1) WO1996014317A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69611598T2 (de) * 1995-09-08 2001-06-07 Uriach & Cia Sa J Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen
ES2165803B1 (es) * 2000-04-10 2003-09-16 Uriach & Cia Sa J Nueva sal de un derivado azo del acido 5-aminosalicilico
GB0013060D0 (en) 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
US6638950B2 (en) 2000-06-21 2003-10-28 Bristol-Myers Squibb Pharma Company Piperidine amides as modulators of chemokine receptor activity
CA2774959C (en) * 2000-08-04 2016-05-31 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
GB0021670D0 (en) 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
GB0117899D0 (en) 2001-07-23 2001-09-12 Astrazeneca Ab Chemical compounds
JP2007500747A (ja) 2003-05-15 2007-01-18 ディーエムアイ バイオサイエンシズ インコーポレイテッド Ｔ細胞媒介性疾患の処置
FR2860514A1 (fr) * 2003-10-03 2005-04-08 Sanofi Synthelabo Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
WO2007101270A1 (en) * 2006-03-02 2007-09-07 Incyte Corporation MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
CA2658913C (en) * 2006-07-24 2015-07-21 Ucb Pharma S.A. Substituted aniline derivatives
KR100737397B1 (ko) 2007-01-31 2007-07-09 한국교세라정공(주) 밀링 커터
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
FR2962649A1 (fr) 2010-07-19 2012-01-20 Conservatoire Nat Arts Et Metiers Traitement d'une pathologie liee a un effet excessif du tnf par un compose de benzene sulfonamide
GB201101517D0 (en) * 2011-01-28 2011-03-16 Proximagen Ltd Receptor antagonists
SG10201608087WA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
EP2766029B1 (en) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
MX355446B (es) 2011-10-28 2018-04-18 Ampio Pharmaceuticals Inc Tratamiento de rinitis.
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
KR20170045274A (ko) 2014-08-18 2017-04-26 앰피오 파마슈티컬스 인코퍼레이티드 관절 징후의 치료
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284359A1 (en) * 1987-03-24 1988-09-28 Takeda Chemical Industries, Ltd. 1,4-Disubstituted piperazine compounds, their production and use
EP0441226A1 (en) * 1990-01-29 1991-08-14 J. URIACH & CIA. S.A. (cyanomethyl)pyridines useful as PAF antagonists
EP0528172A1 (en) * 1991-08-08 1993-02-24 J. URIACH & CIA. S.A. (2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists
WO1993005042A1 (en) * 1991-09-04 1993-03-18 Minnesota Mining And Manufacturing Company 1-substituted 1h-imidazo(4,5-c)quinolin-4-amines; intermediate and pharmaceutical compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0029707B1 (en) * 1979-11-21 1984-02-01 Kyowa Hakko Kogyo Co., Ltd Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
US5283242A (en) * 1991-10-24 1994-02-01 American Home Products Corporation Substituted benzimidazoles and quinazolines as antihypertensives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284359A1 (en) * 1987-03-24 1988-09-28 Takeda Chemical Industries, Ltd. 1,4-Disubstituted piperazine compounds, their production and use
EP0441226A1 (en) * 1990-01-29 1991-08-14 J. URIACH & CIA. S.A. (cyanomethyl)pyridines useful as PAF antagonists
EP0528172A1 (en) * 1991-08-08 1993-02-24 J. URIACH & CIA. S.A. (2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists
WO1993005042A1 (en) * 1991-09-04 1993-03-18 Minnesota Mining And Manufacturing Company 1-substituted 1h-imidazo(4,5-c)quinolin-4-amines; intermediate and pharmaceutical compositions

Also Published As

Publication number Publication date
PT738269E (pt) 2000-08-31
ES2147616T3 (es) 2000-09-16
MX9602559A (es) 1997-07-31
DE69516503T2 (de) 2001-03-15
ATE192152T1 (de) 2000-05-15
DE69516503D1 (de) 2000-05-31
AU3563695A (en) 1996-05-31
NO962855L (no) 1996-07-05
NO962855D0 (no) 1996-07-05
GR3033528T3 (en) 2000-09-29
DK0738269T3 (da) 2000-08-28
JPH09507862A (ja) 1997-08-12
EP0738269A1 (en) 1996-10-23
DK0738269T5 (da) 2000-12-18
NO306345B1 (no) 1999-10-25
WO1996014317A1 (en) 1996-05-17
EP0738269B1 (en) 2000-04-26
JP4018137B2 (ja) 2007-12-05
US5705504A (en) 1998-01-06
ES2087038B1 (es) 1997-03-16
KR100514201B1 (ko) 2005-12-29

Similar Documents

Publication Publication Date Title
ES2087038A1 (es) Nuevas piperidinas con actividad antagonista del paf.
NZ333801A (en) Piperidine and piperazine derivatives and their use as muscarinic antagonists
MY112102A (en) Therapeutic heterocycles.
PL308217A1 (en) Derivatives of 1-(oxo-acetyl)-piperidine-2-carboxylic as agents sensibilising multiple-drug-resistant cancer cells
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
IL114894A (en) Pyrrolidine derivatives as endothelin antagonists, pharmaceutical compositions containing them, and their use in the preparation of medicaments
IL117149A0 (en) Muscarinic antagonists
ATE427936T1 (de) Substituierte piperidin-verbindungen als modulatoren der chemokine receptor aktivitat
DE69715865D1 (de) Muscarin-antagonisten
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
EP0896533A4 (en) PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS
MX9704777A (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen.
ATE201671T1 (de) Chinolon und acridinon derivate zur behandlung der harninkontinenz
IL117093A0 (en) Heterocyclic derivatives
GR3031215T3 (en) Bicyclic heterocycles as neurokinin a antagonists
HK1018265A1 (en) Piperazino derivatives as neurokinin antagonists
MX9708416A (es) Derivados de piperazino como antagonistas de neuroquininas.
GR3032950T3 (en) Substituted fused and bridged bicyclic compounds as therapeutic agents
BG105923A (en) Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
GB9116056D0 (en) Compounds
CA2180660A1 (en) Novel piperidine derivatives with paf antagonist activity
MX9703610A (es) Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19941107

Kind code of ref document: A1

Effective date: 19941107

FD1A Patent lapsed

Effective date: 20051108